期刊文献+

低剂量EPO治疗对急性心肌梗死患者PCI术后血浆HO-1、IL-6及内脂素水平影响 被引量:8

下载PDF
导出
摘要 目的:观察急性心肌梗死患者PCI术后接受低剂量促红细胞生成素(EPO)治疗对血浆血红素加氧酶-1(HO-1)、白细胞介素-6(IL-6)及内脂素水平的影响,探讨EPO对缺血心肌的保护作用。方法:将116例急性ST段抬高型心肌梗死且成功行急诊PCI的患者随机分为EPO组(n=58)和对照组(n=58),EPO组在PCI术后第1、3、5天分别给予EPO3000IU(50ml0.9%氯化钠稀释后静滴),对照组同时静滴等量生理盐水。术后1周复测HO-1、IL-6、内脂素和血常规。结果:治疗1周后EPO组患者血浆HO-1较对照组明显升高,而IL-6及内脂素水平均较对照组明显降低,差异有统计学意义(P<0.05);治疗1周后两组患者血中性粒细胞数、红细胞数、血红蛋白数均无显著差异(P>0.05)。结论:低剂量EPO治疗可有效提高血浆HO-1水平,降低IL-6及内脂素水平,对心脏具有保护作用。
出处 《陕西医学杂志》 CAS 2017年第4期469-471,共3页 Shaanxi Medical Journal
  • 相关文献

参考文献2

二级参考文献40

  • 1李丽,盖鲁粤,杨庭树,陈练,刘宏斌,孙志军,杜洛山.冠状动脉搭桥术后症状复发患者的血管造影特征和缺血原因分析[J].中国循环杂志,2005,20(5):328-331. 被引量:14
  • 2Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coil Cardiol, 1996, 28:616-626.
  • 3Alanbaei M, Alsheikh-Ali AA, Aleinati T, et al. Clinical characteristics and outcomes of patients with acute coronary syndrome and prior coronary artery bypass grafting in a large middle eastern cohort. Open CardiovascMedJ, 2011, 5:196-202.
  • 4Labinaz M, Sketch MH Jr, Ellis SG, et al. Outcome of acute ST- segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. Am Heart J, 2001, 141, :469-477.
  • 5Thygesen K, Alpert JS, Jaffe AS, et al. Third Universal Definition ofMyocardial Infarction. Circulation, 2012, 126:2020-2035.
  • 6Brilakis ES, Rao SV, Banerjee S, et al. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv , 2011, 4:844-850.
  • 7Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coil Cardiol, 2011, 58: e44-122.
  • 8Welsh RC, Granger CB, Westerhout CM, et al. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. JACC Cardiovasc Interv, 2010, 3:343-351.
  • 9Parang P, Arora R. Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol, 2009, 25:e57-62.
  • 10Grines CL, Booth DC, Nissen SE, et al. Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. Am J Cardinl , 1990, 65:1292-1296.

共引文献20

同被引文献81

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部